{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:49:29Z","timestamp":1792601369394,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T00:00:00Z","timestamp":1780790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bonr.2026.101929","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:12:55Z","timestamp":1781107975000},"page":"101929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Fracture risk assessment by dual-energy absorptiometry in osteogenesis imperfecta: A systematic review of measurement sites and its predictive value"],"prefix":"10.1016","volume":"30","author":[{"given":"Karlijn","family":"Scheepens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"den Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Warmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Sakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spaans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"Nijhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrie","family":"Weinans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bonr.2026.101929_bb0005","first-page":"105","article-title":"Alendronate treatment in children with osteogenesis imperfecta","volume":"45","author":"Akcay","year":"2008","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0010","first-page":"63","article-title":"Cyclic pamidronate therapy in children with osteogenesis imperfecta: results of treatment and follow-up after discontinuation","volume":"21","author":"Andiran","year":"2008","journal-title":"London J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0015","first-page":"1","article-title":"Osteogenezis \u0130mperfekta tan\u0131s\u0131 alan hastalar\u0131n retrospektif olarak de\u011ferlendirilmesi","volume":"15","author":"Aslan","year":"2017","journal-title":"Guncel Pediatri"},{"key":"10.1016\/j.bonr.2026.101929_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10118","article-title":"A multicenter observational cohort study to evaluate the effects of bisphosphonate exposure on bone mineral density and other health outcomes in osteogenesis imperfecta","volume":"3","author":"Bains","year":"2019","journal-title":"JBMR Plus"},{"key":"10.1016\/j.bonr.2026.101929_bb0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/bpo.0b013e3180316d06","article-title":"Intravenous pamidronate therapy in osteogenesis imperfecta - response to treatment and factors influencing outcome","volume":"27","author":"Bajpai","year":"2007","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bonr.2026.101929_bb0030","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5582\/irdr.2024.01033","article-title":"Osteogenesis imperfecta in Peruvian children: phenotypic and therapeutic insights from a pediatric hospital","volume":"13","author":"Barba","year":"2024","journal-title":"Intractable Rare Dis. Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0035","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/jpem-2012-0016","article-title":"Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta","volume":"25","author":"Barros","year":"2012","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0040","article-title":"Genotype-based comparison of bone microstructure in adult patients with classical osteogenesis imperfecta","author":"Bartosik","year":"2025","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101929_bb0045","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00004424-199001000-00004","article-title":"Predicting femoral neck strength from bone mineral data: a structural approach","volume":"25","author":"Beck","year":"1990","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.bonr.2026.101929_bb0050","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/jbmr.1942","article-title":"Skeletal clinical characteristics of osteogenesis imperfecta caused by haploinsufficiency mutations in COL1A1","volume":"28","author":"Ben Amor","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0055","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/bmj.325.7362.484","article-title":"Bone mineral density scans","volume":"325","author":"Berger","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.bonr.2026.101929_bb0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000369582","article-title":"The long-term effects of switching from active intravenous bisphosphonate treatment to low-dose maintenance therapy in children with osteogenesis imperfecta","volume":"83","author":"Biggin","year":"2015","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0065","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.15537\/1658-3175.2697","article-title":"Radiological features of bisphosphonate therapy in children with osteogenesis imperfecta","volume":"25","author":"Bin-Abbas","year":"2004","journal-title":"Article Saudi Med."},{"key":"10.1016\/j.bonr.2026.101929_bb0070","doi-asserted-by":"crossref","DOI":"10.1007\/s00247-008-0808-y","article-title":"Pediatric DXA: technique, interpretation and clinical applications","author":"Binkovitz","year":"2008","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.bonr.2026.101929_bb0075","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1359\/jbmr.090712","article-title":"A randomized, controlled dose-ranging study of risedronate in children with moderate and severe osteogenesis imperfecta","volume":"25","author":"Bishop","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0080","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","article-title":"Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Bishop","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bonr.2026.101929_bb0085","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1210\/clinem\/dgae791","article-title":"Genetics and bone mineral density predict the fractures in adults with osteogenesis imperfecta: a prospective study","volume":"110","author":"Blandin","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00198-012-2188-2","article-title":"Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study","volume":"24","author":"Boutroy","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101929_bb0095","first-page":"55","article-title":"Safety and efficacy of intravenous Zoledronic acid in Paediatric osteoporosis","volume":"22","author":"Brown","year":"2009","journal-title":"London J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb9000","doi-asserted-by":"crossref","DOI":"10.1111\/jre.13405","article-title":"Risk of Bias Evaluation of Cross-Sectional Studies: Adaptation of the Newcastle-Ottawa Scale","author":"Carra","year":"2025","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.5650070204","article-title":"New approaches for interpreting projected bone densitometry data","volume":"7","author":"Carter","year":"1992","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0105","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5152\/TurkArchPediatr.2023.22248","article-title":"Clinical characteristics and treatment outcomes of children with primary osteoporosis","volume":"58","author":"\u00c7etin","year":"2023","journal-title":"Turk. Arch. Pediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.nut.2011.04.003","article-title":"Do patients with osteogenesis imperfecta need individualized nutritional support?","volume":"28","author":"Chagas","year":"2012","journal-title":"Nutrition"},{"key":"10.1016\/j.bonr.2026.101929_bb0115","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s41431-024-01645-4","article-title":"Clinical spectrum of rare bone fragility disorders and response to bisphosphonate treatment: a retrospective study","volume":"32","author":"Charpi\u00e9","year":"2024","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bonr.2026.101929_bb0120","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-023-02906-z","article-title":"Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients","volume":"18","author":"Chen","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bonr.2026.101929_bb0125","first-page":"25","article-title":"Efficacy of oral alendronate in children with osteogenesis imperfecta","author":"Cho","year":"2005","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bonr.2026.101929_bb0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4055\/cios20060","article-title":"Management of osteogenesis imperfecta: a multidisciplinary comprehensive approach","volume":"12","author":"Cho","year":"2020","journal-title":"Clin. Orthop. Surg."},{"key":"10.1016\/j.bonr.2026.101929_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.6065\/apem.2142144.072","article-title":"Genotype-phenotype correlations and long-term efficacy of pamidronate therapy in patients with osteogenesis imperfecta","volume":"27","author":"Choi","year":"2022","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s40842-018-0062-7","article-title":"The challenges of diagnosing osteoporosis and the limitations of currently available tools","volume":"4","author":"Choksi","year":"2018","journal-title":"Clin. Diabetes Endocrinol."},{"key":"10.1016\/j.bonr.2026.101929_bb0145","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1002\/jbmr.4722","article-title":"Bone mass, density, geometry, and stress\u2013strain index in adults with osteogenesis imperfecta type I and their associations with physical activity and muscle function parameters","volume":"37","author":"Coussens","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0150","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bone.2004.06.009","article-title":"The relationship between lean body mass and bone mineral content in paediatric health and disease","volume":"35","author":"Crabtree","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101929_bb0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.52628\/88.2.9117","article-title":"Quantitative gait analysis in children with osteogenesis imperfecta: relationship between gait deviations and clinical features","volume":"88","author":"De Wouters","year":"2022","journal-title":"Acta Orthop. Belg."},{"key":"10.1016\/j.bonr.2026.101929_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115608","article-title":"Vertebral fracture assessment (VFA) for monitoring vertebral reshaping in children and adolescents with osteogenesis imperfecta treated with intravenous neridronate","volume":"143","author":"Diacinti","year":"2021","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101929_bb0165","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.apmr.2003.08.085","article-title":"Osteogenesis imperfecta in childhood: impairment and disability. A prospective study with 4-year follow-up","volume":"85","author":"Engelbert","year":"2004","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.bonr.2026.101929_bb0170","doi-asserted-by":"crossref","DOI":"10.1007\/s11914-021-00665-z","article-title":"Osteogenesis imperfecta\u2014who needs rodding surgery?","author":"Fassier","year":"2021","journal-title":"Curr. Osteoporos. Rep."},{"key":"10.1016\/j.bonr.2026.101929_bb0175","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00198-005-0019-4","article-title":"Femur strength index predicts hip fracture independent of bone density and hip axis length","volume":"17","author":"Faulkner","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101929_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4321\/S1889-836X2022000400005","article-title":"Usefulness of the trabecular bone score in adult subjects with osteogenesis imperfecta","volume":"14","author":"Florez","year":"2022","journal-title":"Rev. Osteoporos. Metab. Miner."},{"key":"10.1016\/j.bonr.2026.101929_bb0185","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/jbmr.1592","article-title":"Bone geometry, density, and microarchitecture in the distal radius and tibia in adults with osteogenesis imperfecta type i assessed by high-resolution pQCT","volume":"27","author":"Folkestad","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jbspin.2004.08.011","article-title":"Benefits of pamidronate in children with osteogenesis imperfecta: an open prospective study","volume":"72","author":"Forin","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bonr.2026.101929_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1500023","article-title":"Trabecular bone scores in children with osteogenesis imperfecta respond differently to bisphosphonate treatment depending on disease severity","volume":"12","author":"Futagawa","year":"2024","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/JCD:6:2:173","article-title":"The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta","volume":"6","author":"Gatti","year":"2003","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bonr.2026.101929_bb0205","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20221016","article-title":"High-resolution peripheral quantitative computed tomography: research or clinical practice?","volume":"96","author":"Gazzotti","year":"2023","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.bonr.2026.101929_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2024.104926","article-title":"Imaging in osteogenesis imperfecta: where we are and where we are going","volume":"68","author":"Gazzotti","year":"2024","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bonr.2026.101929_bb0215","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199810013391402","article-title":"Cyclic administration of pamidronate therapy in children with severe osteogenesis imperfecta","volume":"339","author":"Glorieux","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bonr.2026.101929_bb0220","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jbmr\/zjae112","article-title":"Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study","volume":"39","author":"Glorieux","year":"2024","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.24953\/turkjpediatr.2006.2612","article-title":"Low-dose intravenous pamidronate treatment in osteogenesis imperfecta","volume":"48","author":"G\u00f6ksen","year":"2006","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0230","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00247-004-1393-3","article-title":"Bone densitometry in pediatric patients treated with pamidronate","volume":"35","author":"Grissom","year":"2005","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.bonr.2026.101929_bb0235","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1088\/0031-9155\/48\/12\/305","article-title":"Dual energy x-ray laser measurement of calcaneal bone mineral density","volume":"48","author":"Hakulinen","year":"2003","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.bonr.2026.101929_bb0240","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1007\/s00198-016-3653-0","article-title":"Skeletal phenotypes in adult patients with osteogenesis imperfecta\u2014correlations with COL1A1\/COL1A2 genotype and collagen structure","volume":"27","author":"Hald","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101929_bb0245","first-page":"114","article-title":"Mechanical basis of bone strength: influence of bone material, bone structure and muscle action","volume":"17","author":"Hart","year":"2017","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"10.1016\/j.bonr.2026.101929_bb0250","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000323370","article-title":"Intravenous pamidronate treatment improves growth in prepubertal osteogenesis imperfecta patients","volume":"75","author":"Heino","year":"2011","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0255","article-title":"Bone microstructural and strength changes over 1 year in children with osteogenesis imperfecta are comparable to age- and sex-matched healthy controls","author":"Hosseinitabatabaei","year":"2025","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0260","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-019-1197-z","article-title":"Individualized treatment with denosumab in children with osteogenesis imperfecta - follow up of a trial cohort","volume":"14","author":"Hoyer-Kuhn","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bonr.2026.101929_bb0265","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2106\/00004623-200606000-00021","article-title":"Functional significance of bone density measurements in children with osteogenesis imperfecta","volume":"88-A","author":"Huang","year":"2006","journal-title":"J. Bone Joint Surg."},{"key":"10.1016\/j.bonr.2026.101929_bb0270","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.bone.2017.07.004","article-title":"Treatment with neridronate in children and adolescents with osteogenesis imperfecta: data from open-label, not controlled, three-year Italian study","volume":"103","author":"Idolazzi","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101929_bb0275","series-title":"Official Pediatric Positions [WWW Document]","author":"International Society For Clinical Densitometry","year":"2019"},{"key":"10.1016\/j.bonr.2026.101929_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1390668","article-title":"The vitamin D status in a Chinese osteogenesis imperfecta population and its correlation with bone metabolic markers and bone density","volume":"11","author":"Jiang","year":"2024","journal-title":"Front. Nutr."},{"key":"10.1016\/j.bonr.2026.101929_bb0285","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/BF01945218","article-title":"Determination of the electronic density and the average atomic number of tissues in man by \u03b3-ray attenuation","volume":"30","author":"Joyet","year":"1974","journal-title":"Experientia"},{"key":"10.1016\/j.bonr.2026.101929_bb0290","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00774-017-0840-9","article-title":"Responsiveness to pamidronate treatment is not related to the genotype of type I collagen in patients with osteogenesis imperfecta","volume":"36","author":"Kanno","year":"2018","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0295","first-page":"1283","article-title":"Lumbar spine bone mineral apparent density in children: results from the bone mineral density in childhood study","volume":"104","author":"Kindler","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0300","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00256-012-1512-4","article-title":"Femoral geometric parameters and BMD measurements by DXA in adult patients with different types of osteogenesis imperfecta","volume":"42","author":"Kocijan","year":"2013","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.bonr.2026.101929_bb0305","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s00198-015-3156-4","article-title":"Bone structure assessed by HR-pQCT, TBS and DXL in adult patients with different types of osteogenesis imperfecta","volume":"26","author":"Kocijan","year":"2015","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101929_bb0310","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3109\/17453674.2013.831321","article-title":"Bone mineral density in developing children with osteogenesis imperfecta","volume":"84","author":"Kok","year":"2013","journal-title":"Acta Orthop."},{"key":"10.1016\/j.bonr.2026.101929_bb0315","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-02148-x","article-title":"Osteogenesis imperfecta: characterization of fractures during pregnancy and post-partum","volume":"17","author":"Koumakis","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bonr.2026.101929_bb0320","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0169-6009(92)90712-M","article-title":"Bone densitometry of the spine and femur in children by dual-energy x-ray absorptiometry","volume":"17","author":"Kr\u00f6ger","year":"1992","journal-title":"Bone Miner."},{"key":"10.1016\/j.bonr.2026.101929_bb0325","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0169-6009(08)80094-3","article-title":"Development of bone mass and bone density of the spine and femoral neck - a prospective study of 65 children and adolescents","volume":"23","author":"Kr\u00f6ger","year":"1993","journal-title":"Bone Miner."},{"key":"10.1016\/j.bonr.2026.101929_bb0330","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1515\/jpem-2015-0351","article-title":"Zoledronate for osteogenesis imperfecta: evaluation of safety profile in children","volume":"29","author":"Kumar","year":"2016","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0335","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jfma.2014.01.016","article-title":"Complement component C3: serologic signature for osteogenesis imperfecta. Analysis of a comparative proteomic study","volume":"114","author":"Kuo","year":"2015","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.bonr.2026.101929_bb0340","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00774-014-0618-2","article-title":"Beneficial effects of intravenous pamidronate treatment in children with osteogenesis imperfecta under 24 months of age","volume":"33","author":"Kusumi","year":"2015","journal-title":"J. Bone Miner. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0345","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1359\/JBMR.050109","article-title":"Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement","volume":"20","author":"Letocha","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0350","first-page":"3049","article-title":"Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta","volume":"124","author":"Li","year":"2011","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bonr.2026.101929_bb0355","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1159\/000512730","article-title":"Outcomes of zoledronic acid use in paediatric conditions","volume":"93","author":"Lim","year":"2021","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0360","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-015-0370-2","article-title":"Genotype and phenotype analysis of Taiwanese patients with osteogenesis imperfecta","volume":"10","author":"Lin","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bonr.2026.101929_bb0365","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1210\/clinem\/dgae012","article-title":"Efficacy and safety of denosumab vs zoledronic acid in OI adults: a prospective, open-label, randomized study","volume":"109","author":"Lin","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0370","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1210\/clinem\/dgad035","article-title":"Approach to the patient: pharmacological therapies for fracture risk reduction in adults with osteogenesis imperfecta","volume":"108","author":"Liu","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0375","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1210\/clinem\/dgad732","article-title":"Safety and efficacy of denosumab in children with osteogenesis imperfecta\u2014the first prospective comparative study","volume":"109","author":"Liu","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0380","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00198-025-07423-2","article-title":"TBS as a complementary tool for assessing vertebral fractures and spinal deformity in children and adolescents with osteogenesis imperfecta","volume":"36","author":"Liu","year":"2025","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101929_bb0385","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1651-2227.1999.tb00993.x","article-title":"Bone mineral content and collagen defects in osteogenesis imperfecta","volume":"88","author":"Lund","year":"1999","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0390","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1651-2227.2003.tb00577.x","article-title":"Treatment of children with osteogenesis imperfecta in Estonia","volume":"92","author":"Maasalu","year":"2003","journal-title":"Acta Paediatr. Int. J. Paediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0395","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.bonr.2026.101929_bb0400","doi-asserted-by":"crossref","first-page":"290","DOI":"10.11005\/jbm.24.767","article-title":"Zoledronate therapy in osteogenesis imperfecta: perspectives in Indonesia tertiary hospital","volume":"31","author":"Martanto","year":"2024","journal-title":"J. Bone Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0405","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0021-9290(84)90010-1","article-title":"Non-invasive measurement of long bone cross-sectional moment of inertia by photon absorptiometry","volume":"17","author":"Martin","year":"1984","journal-title":"J. Biomech."},{"key":"10.1016\/j.bonr.2026.101929_bb0410","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejrad.2018.06.001","article-title":"Pediatric dual-energy X-ray absorptiometry in clinical practice: what the clinicians need to know","volume":"105","author":"Messina","year":"2018","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.bonr.2026.101929_bb0415","doi-asserted-by":"crossref","DOI":"10.1186\/s12887-020-02491-1","article-title":"Bone density, fractures and the associated factors in iranian children and adolescent with osteogenesis imperfecta","volume":"21","author":"Mohsenzade","year":"2021","journal-title":"BMC Pediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0420","article-title":"Osteogenesis imperfecta: a cross-sectional study of skeletal and extraskeletal features in a large cohort of Italian patients","volume":"14","author":"Mordenti","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.bonr.2026.101929_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26167953","article-title":"Serum osteocalcin in pediatric osteogenesis imperfecta: impact of disease type and bisphosphonate therapy","volume":"26","author":"Nowicki","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bonr.2026.101929_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0290812","article-title":"Association of trabecular bone score and bone mineral apparent density with the severity of bone fragility in children and adolescents with osteogenesis imperfecta: a cross-sectional study","volume":"18","author":"Ohata","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bonr.2026.101929_bb0435","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00198-015-3216-9","article-title":"Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study","volume":"27","author":"Otaify","year":"2016","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bonr.2026.101929_bb0440","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1055\/a-1730-5412","article-title":"Growth and pubertal features in a cohort of 83 patients with osteogenesis imperfecta","volume":"234","author":"\u00d6zt\u00fcrk","year":"2022","journal-title":"Klin. Padiatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0445","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/cge.12409","article-title":"A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers","volume":"87","author":"Patel","year":"2015","journal-title":"Clin. Genet."},{"key":"10.1016\/j.bonr.2026.101929_bb0450","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/pgmj.70.820.104","article-title":"Bone density in osteogenesis imperfecta may well be normal","volume":"70","author":"Paterson","year":"1994","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.bonr.2026.101929_bb0455","series-title":"Bone Mass, Size, and Density in Children and Adolescents with Osteogenesis Imperfecta: Effect of Intravenous Pamidronate Therapy","author":"Rauch","year":"2003"},{"key":"10.1016\/j.bonr.2026.101929_bb0460","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1210\/jc.2005-2413","article-title":"Pamidronate in children and adolescents with osteogenesis imperfecta: effect of treatment discontinuation","volume":"91","author":"Rauch","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0465","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2005-2036","article-title":"Pamidronate in children with osteogenesis imperfecta: histomorphometric effects of long-term therapy","volume":"91","author":"Rauch","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0470","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jocd.2018.09.001","article-title":"TBS as a tool to differentiate the impact of antiresorptives on cortical and trabecular bone in children with osteogenesis imperfecta","volume":"22","author":"Rehberg","year":"2019","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bonr.2026.101929_bb0475","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s002239900387","article-title":"Differing lumbar vertebral mineralization rates in ambulatory pediatric patients with osteogenesis imperfecta*","volume":"62","author":"Reinus","year":"1998","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2026.101929_bb0480","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.29271\/jcpsp.2022.09.1165","article-title":"Safety and efficacy of Zoledronic acid in children with osteogenesis imperfecta","volume":"32","author":"Riaz","year":"2022","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.bonr.2026.101929_bb0485","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1002\/jbmr.3833","article-title":"Osteogenesis imperfecta: skeletal outcomes after bisphosphonate discontinuation at final height","volume":"34","author":"Robinson","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bonr.2026.101929_bb0490","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00223-018-0447-8","article-title":"Comparison of bone microarchitecture between adult osteogenesis imperfecta and early-onset osteoporosis","volume":"103","author":"Rolvien","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bonr.2026.101929_bb0495","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(04)16101-1","article-title":"Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study","volume":"363","author":"Sakkers","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bonr.2026.101929_bb0500","first-page":"73","article-title":"Cyclic Pamidronate therapy in children with osteogenesis imperfecta","volume":"23","author":"Salehpour","year":"2010","journal-title":"London J. Pediatr. Endocrinol."},{"key":"10.1016\/j.bonr.2026.101929_bb0505","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/archdischild-2017-313234","article-title":"Efficacy and treatment costs of zoledronate versus pamidronate in paediatric osteoporosis","volume":"103","author":"Saraff","year":"2018","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.bonr.2026.101929_bb0510","article-title":"Prognostic factors for mobility in children with osteogenesis imperfecta","volume":"101","author":"Sawamura","year":"2022","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.bonr.2026.101929_bb0515","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01.bpo.0000176162.78980.ed","article-title":"Impact of alendronate on quality of life in children with osteogenesis imperfecta","volume":"25","author":"Seikaly","year":"2005","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bonr.2026.101929_bb0520","article-title":"SERPINF1 gene variants causing late-onset progressive deforming osteogenesis imperfecta \u2013 a study of 18 patients from India","volume":"18","author":"Selina","year":"2023","journal-title":"Bone Rep."},{"key":"10.1016\/j.bonr.2026.101929_bb0525","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.64023","article-title":"COL1A1 and COL1A2 gene variants causing osteogenesis imperfecta in a major referral Center of India","volume":"197","author":"Selina","year":"2025","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bonr.2026.101929_bb0530","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1179\/146532807X170493","article-title":"Oral bisphosphonate treatment for osteogenesis imperfecta - an Indian perspective","volume":"27","author":"Shah","year":"2007","journal-title":"Ann. Trop. Paediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0535","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(78)90763-8","article-title":"Classification of osteogenesis imperfecta","volume":"311","author":"Sillence","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.bonr.2026.101929_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116282","article-title":"Fabric-elasticity relationships of tibial trabecular bone are similar in osteogenesis imperfecta and healthy individuals","volume":"155","author":"Simon","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101929_bb0545","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1210\/clinem\/dgac366","article-title":"Relationship of pathogenic mutations and responses to zoledronic acid in a cohort of osteogenesis imperfecta children","volume":"107","author":"Sun","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0550","doi-asserted-by":"crossref","first-page":"E558","DOI":"10.1097\/BPO.0000000000001333","article-title":"Olecranon fractures in pediatric patients with osteogenesis imperfecta","volume":"39","author":"Tayne","year":"2019","journal-title":"J. Pediatr. Orthop."},{"key":"10.1016\/j.bonr.2026.101929_bb0555","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15030250","article-title":"Complex analysis of micronutrient levels and bone mineral density in patients with different types of osteogenesis imperfecta","volume":"15","author":"Valeeva","year":"2025","journal-title":"Diagnostics"},{"key":"10.1016\/j.bonr.2026.101929_bb0560","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/ajmg.a.36545","article-title":"Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment","volume":"164","author":"Van Dijk","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bonr.2026.101929_bb0565","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000323368","article-title":"Zoledronic acid treatment in children with osteogenesis imperfecta","volume":"75","author":"Vuorimies","year":"2011","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.bonr.2026.101929_bb0570","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jbspin.2004.09.005","article-title":"Effect of alendronate therapy in children with osteogenesis imperfecta","volume":"72","author":"Vysko\u010dil","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.bonr.2026.101929_bb0575","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/BRS.0b013e31811ec2d9","article-title":"Correlation of scoliotic curvature with Z-score bone mineral density and body mass index in patients with osteogenesis imperfecta","volume":"32","author":"Watanabe","year":"2007","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.bonr.2026.101929_bb0580","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5644\/ama2006-124.343","article-title":"Clinical manifestations and medical imaging of osteogenesis imperfecta: fetal through adulthood","volume":"50","author":"Weaver","year":"2021","journal-title":"Acta Med. Acad."},{"key":"10.1016\/j.bonr.2026.101929_bb0585","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11657-011-0054-z","article-title":"Bone mass, bone markers and prevalence of fractures in adults with osteogenesis imperfecta","volume":"6","author":"Wekre","year":"2011","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.bonr.2026.101929_bb0590","first-page":"163","article-title":"Pamidronate treatment of osteogenesis imperfecta-lack of correlation between clinical severity, age at onset of treatment, predicted collagen mutation and treatment response*","volume":"15","author":"Zacharin","year":"2002","journal-title":"London J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0595","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jhn.12657","article-title":"Calcium intake improvement after nutritional intervention in paediatric patients with osteogenesis imperfecta","volume":"32","author":"Zambrano","year":"2019","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.bonr.2026.101929_bb0600","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bone.2005.07.020","article-title":"The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V","volume":"38","author":"Zeitlin","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bonr.2026.101929_bb0605","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height adjustment in assessing dual energy X-ray absorptiometry measurements of bone mass and density in children","volume":"95","author":"Zemel","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0610","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","article-title":"Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study","volume":"96","author":"Zemel","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bonr.2026.101929_bb0615","article-title":"Skeletal outcomes of patients with osteogenesis imperfecta during drug holiday of bisphosphonates: a real-world study","volume":"Lausanne). 13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol."}],"container-title":["Bone Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352187226000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:41:24Z","timestamp":1789544484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352187226000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":124,"alternative-id":["S2352187226000331"],"URL":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101929","relation":{},"ISSN":["2352-1872"],"issn-type":[{"value":"2352-1872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fracture risk assessment by dual-energy absorptiometry in osteogenesis imperfecta: A systematic review of measurement sites and its predictive value","name":"articletitle","label":"Article Title"},{"value":"Bone Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bonr.2026.101929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101929"}}